01 1Alivira Animal Health Limited
02 1Hubei Honch Pharmaceutical Co., Ltd.
03 1LAURUS SYNTHESIS PVT LTD
04 1Lonza AG
01 2LUFENURON
02 2Lufenuron
01 1China
02 2India
03 1U.S.A
NDC Package Code : 86055-0029
Start Marketing Date : 2023-05-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62158-0004
Start Marketing Date : 2018-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69843-001
Start Marketing Date : 2024-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0300
Start Marketing Date : 2011-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
82
PharmaCompass offers a list of Lufenuron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lufenuron manufacturer or Lufenuron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lufenuron manufacturer or Lufenuron supplier.
PharmaCompass also assists you with knowing the Lufenuron API Price utilized in the formulation of products. Lufenuron API Price is not always fixed or binding as the Lufenuron Price is obtained through a variety of data sources. The Lufenuron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard, including repackagers and relabelers. The FDA regulates Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard supplier is an individual or a company that provides Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard active pharmaceutical ingredient (API) or Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard finished formulations upon request. The Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers may include Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API manufacturers, exporters, distributors and traders.
click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard suppliers with NDC on PharmaCompass.
We have 4 companies offering Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard
Get in contact with the supplier of your choice:
